Back to search
FDAFDA · Food and drugs·Recall number D-0124-2016

TESTOSTERONE, Pellet, 200 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314

Published November 4, 2015 · Recall initiated: July 24, 2015

Summary

FDA records drug Class II recall D-0124-2016, published November 4, 2015 and initiated July 24, 2015. Recalling firm: JD & SN Inc., dba Moses Lake Professional Pharmacy; Status: Terminated; Reported quantity: 298 pellet; Lot: 01202015@19, 05192015@3, 07222014@27, 08192014@4, 09042014@5, 09232014@21, 10032014@24, 10092014@12, 12012014@16, t01152015@6, t02232015@23, t03122015@1, t03202015@10, t04232015@11, t05062015@22, t05182015@29, t06012015@12, t06112015@10, t06132014@15, t08112014@30, t12182014@19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
JD & SN Inc., dba Moses Lake Professional Pharmacy
Distributor
Nationwide
Lot
01202015@19, 05192015@3, 07222014@27, 08192014@4, 09042014@5, 09232014@21, 10032014@24, 10092014@12, 12012014@16, t01152015@6, t02232015@23, t03122015@1, t03202015@10, t04232015@11, t05062015@22, t05182015@29, t06012015@12, t06112015@10, t06132014@15, t08112014@30, t12182014@19.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TESTOSTERONE, Pellet, 200 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314 recalled?

Yes. FDA published recall D-0124-2016 on November 4, 2015. Reported hazard: Lack of Assurance of Sterility; all sterile human compounded drugs within expiry

What should I do if I have this product?

Voluntary: Firm initiated · Press Release